首页> 外国专利> Amelioration the adverse effects of ageing of mammalian cells - involves contacting the cells with a compsn. contg. a 6-(substd. amino)-purine cytokinin or kinetin for in=vivo culture

Amelioration the adverse effects of ageing of mammalian cells - involves contacting the cells with a compsn. contg. a 6-(substd. amino)-purine cytokinin or kinetin for in=vivo culture

机译:改善哺乳动物细胞衰老的不利影响-涉及使细胞与复合物接触。续用于体内培养的6-(亚氨基)-嘌呤细胞分裂素或激动素

摘要

Ameliorating the adverse effects of ageing on mammalian cells comprises; contacting the cells with a compsn. that contains a 6-(substd. amino) purine cytokinin in a concn. sufficient to ameliorate the adverse effects of ageing. The rate of development of characteristics of ageing is reversed or slowed, and the growth rate and total proliferative capacity of the cells, after contact with the compsn., is the same as prior to contact. Pref. the cytokinin is of formula (I). In (I) R1 = furfuryl, phenyl, benzyl, 4-6C n-alkyl, cyclohexylmethyl, (3-hydroxymethyl-3-methyl)allyl or 3,3-dimethylallyl. (I) is most esp. furfuryladenine (kinetin).
机译:改善衰老对哺乳动物细胞的不利影响包括:用compsn接触细胞。含有6-(亚氨基)嘌呤细胞分裂素。足以缓解衰老的不利影响。衰老特征的发展速度被逆转或减慢,与复合物接触后,细胞的生长速度和总增殖能力与接触前相同。首选细胞分裂素具有式(I)。在(I)中,R 1 =糠基,苯基,苄基,4-6C正烷基,环己基甲基,(3-羟甲基-3-甲基)烯丙基或3,3-二甲基烯丙基。 (I)最重要。糠醛腺嘌呤(动蛋白)。

著录项

  • 公开/公告号FI111219B

    专利类型

  • 公开/公告日2003-06-30

    原文格式PDF

  • 申请/专利权人 SENETEKPLC;

    申请/专利号FI19930005039

  • 发明设计人 RATTANSURESH I.S.;

    申请日1993-11-15

  • 分类号A61K7/48;

  • 国家 FI

  • 入库时间 2022-08-22 00:03:07

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号